Evidence map›Paper›PMID 27076103›Full record

ArticleThe Journal of antimicrobial chemotherapy2016

Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Yiying Huang, Md Tozammel Hoque, Mohammad-Ali Jenabian, Kishanda Vyboh, Sana-Kay Whyte, Nancy L Sheehan, Pierre Brassard, Maud Bélanger, Nicolas Chomont, Courtney V Fletcher and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Testis Is a Sanctuary Site for HIV-1.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  12. Drug Transporters at the Human Blood-Testis Barrier.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  13. Review
  14. Drug transport across the blood-testis barrier.American journal of translational research · 2022
    Review
  15. Review
  16. Implications of Species Differences in Function and Localization of Transporters at the Blood-Testis Barrier.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  17. Pharmacology of HIV Cure: Site of Action.Clinical pharmacology and therapeutics · 2021
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Yiying HuangDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.
Md Tozammel HoqueDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.
Mohammad-Ali JenabianDepartment of Biological Sciences, Université du Québec à Montréal (UQAM), Montréal, Canada.
Kishanda VybohChronic Viral Illness Service, McGill University Health Centre, Montréal, Canada.
Sana-Kay WhyteDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.
Nancy L SheehanFaculty of Pharmacy, Université de Montréal, Montréal, Canada.
Pierre BrassardMetropolitan Centre of Plastic Surgery, Montréal, Canada.
Maud BélangerMetropolitan Centre of Plastic Surgery, Montréal, Canada.
Nicolas ChomontUniversity of Montréal Hospital Research Centre, Montréal, Canada.
Courtney V FletcherAntiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, NE, USA.
Jean-Pierre RoutyChronic Viral Illness Service, McGill University Health Centre, Montréal, Canada.
Reina BendayanDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada r.bendayan@utoronto.ca.
University of Toronto · CAMcGill University Health Centre · CAUniversité de Montréal · CAUniversité du Québec à Montréal · CAUniversity of Nebraska Medical Center · US

Funding

Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
CIHR 296635CIHR HIG-133050NIAID NIH HHS UM1 AI106701
6 · The paper itself

Abstract

objectivesThe testes are a potential viral sanctuary site for HIV-1 infection. Our study aims to provide insight into the expression and localization of key drug transporters and metabolic enzymes relevant to ART in this tissue compartment.

methodsWe characterized gene and protein expression of 12 representative drug transporters and two metabolic enzymes in testicular tissue samples obtained from uninfected (n = 8) and virally suppressed HIV-1-infected subjects on ART (n = 5) and quantified antiretroviral drug concentrations in plasma and testicular tissues using LC/MS/MS from HIV-1-infected subjects.

resultsOur data demonstrate that key ABC drug transporters (permeability glycoprotein, multidrug-resistance protein 1, 2 and 4, and breast cancer resistance protein), solute carrier transporters (organic anion transporting polypeptides 1B1 and 2B1, organic anion transporter 1, concentrative nucleoside transporter 1, equilibrative nucleoside transporter 2) and cytochrome P450 metabolic enzymes (CYP3A4 and CYP2D6) previously shown to interact with many commonly used antiretroviral drugs are expressed at the mRNA and protein level in the testes of both subject groups and localize primarily at the blood-testis barrier, with no significant differences between the two groups. Furthermore, we observed that PIs known to be substrates for ATP-binding cassette membrane transporters, displayed variable testicular tissue penetration, with darunavir concentrations falling below therapeutic values. In contrast, the NRTIs emtricitabine, lamivudine and tenofovir displayed favourable tissue penetration, reaching concentrations comparable to plasma levels. We also demonstrated that nuclear receptors, peroxisome proliferator-activated receptors α and γ exhibited higher gene expression in the testicular tissue compared with pregnane X receptor and constitutive androstane receptor, suggesting a potential regulatory pathway governing drug transporter and metabolic enzyme expression in this tissue compartment.

conclusionsOur data suggest the testes are a complex pharmacological compartment that can restrict the distribution of certain antiretroviral drugs and potentially contribute to HIV-1 persistence.

Indexed as

AdultAnti-Retroviral AgentsBiotransformationChromatography, LiquidEnzymesGene Expression ProfilingHumansMaleMembrane Transport ProteinsMiddle AgedPlasmaProteomeTandem Mass SpectrometryTestisYoung AdultAnti-Retroviral AgentsEnzymesMembrane Transport ProteinsProteome

Identifiers

PMID27076103
PMCPMC4896405
OpenAlexW2339878931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.